Shopping Cart
Remove All
Your shopping cart is currently empty
Iguratimod
Copy Product Info
🥰Excellent
Catalog No. T5032Cas No. 123663-49-0
Alias T614
Iguratimod (T614) is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.
Iguratimod
Copy Product Info🥰Excellent
Purity: 99.93%
Catalog No. T5032Alias T614Cas No. 123663-49-0
Iguratimod (T614) is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $43 | In Stock | In Stock | |
| 10 mg | $61 | In Stock | In Stock | |
| 25 mg | $113 | In Stock | In Stock | |
| 50 mg | $207 | In Stock | In Stock | |
| 100 mg | $269 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $48 | In Stock | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Iguratimod AI Summary
Iguratimod exhibits multiple bioactivities, including inhibition of recombinant human Macrophage Migration Inhibitory Factor (MIF) tautomerase activity with an IC50 value of 6810.0 nM, and antiviral activity against SARS-CoV-2. Specifically, it inhibits SARS-CoV-2 induced cytotoxicity of Caco-2 cells by 14.87% at a 10 uM concentration over 48 hours as determined by high content imaging. It also shows inhibition of SARS-CoV-2 3CL-Pro protease activity at 20 µM, demonstrating a reduction of 8.67% and 166.31% in two separate FRET-based assays. Additionally, it inhibits SARS-CoV-2 cytotoxicity in VERO-6 cells with an IC50 greater than 20,000 nM. Iguratimod also inhibits human HDAC6 activity by 20.1% using a commercial peptide substrate, while showing a negative inhibition of -12.77% with a custom peptide. Furthermore, it exhibits an agonistic activity towards human ADORA3 with an AC50 of 1435.7 nM and inhibition of human PDE4D with an AC50 of 9800.1 nM, indicating potential in modulating these specific receptors and enzymes..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Iguratimod (T614) is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM. |
| Targets&IC50 | MIF:6.81μM, COX-2:20μM |
| Synonyms | T614 |
| Molecular Weight | 374.37 |
| Formula | C17H14N2O6S |
| Cas No. | 123663-49-0 |
| Smiles | O=C1C=2C(=CC(NS(C)(=O)=O)=C(OC3=CC=CC=C3)C2)OC=C1NC=O |
| Relative Density. | 1.52 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 10 mg/mL (26.71 mM), Sonication is recommended.  | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Iguratimod | purchase Iguratimod | Iguratimod cost | order Iguratimod | Iguratimod chemical structure | Iguratimod formula | Iguratimod molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.